Improvements with Alemtuzumab in Clinical and Mri Disease Activity Outcomes in Rrms Patients Across Age Groups: Care-Ms I and Ii 8-Year Follow-Up
AuthID
P-00Q-VY6
P-00Q-VY6
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service